SCHEDULE: Copeland Capital Management Reports 5.21% Stake in LeMaitre Vascular Inc.

Copeland Capital Management has disclosed a 5.21% ownership stake in LeMaitre Vascular Inc. as of December 31, 2024.

Summary

• Copeland Capital Management has filed a Schedule 13G, reporting their beneficial ownership of LeMaitre Vascular Inc. common stock.
• As of December 31, 2024, Copeland Capital Management beneficially owns 988,980 shares, representing 5.21% of the outstanding common stock.
• Of the total shares, 803,212 are held with sole voting and dispositive power, while 185,768 are held with shared voting and dispositive power.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing indicating a significant investment, which is generally neutral to positive. There is no indication of any negative sentiment.

Positives

• The filing indicates a significant investment by Copeland Capital Management in LeMaitre Vascular Inc.

Industry Context

This filing is a standard disclosure for investment firms that acquire more than 5% of a company's stock, and it provides transparency to the market about significant ownership changes.

Comparison to Industry Standards

• Schedule 13G filings are common for institutional investors like Copeland Capital Management when they reach a 5% ownership threshold in a publicly traded company.
• Similar filings are made by other investment firms such as BlackRock, Vanguard, and State Street when they acquire significant stakes in companies.
• The 5.21% stake is within the typical range for such filings, indicating a notable but not controlling interest.

Stakeholder Impact

• The disclosure of a 5.21% stake by Copeland Capital Management may be of interest to current shareholders of LeMaitre Vascular Inc.

Key Dates

Keywords

Schedule 13G, Copeland Capital Management, LeMaitre Vascular Inc, Beneficial Ownership, Investment, Common Stock